Managing blood sugar while carrying a baby is not just about eating right; it often requires medication. If you have been diagnosed with gestational diabetes or are navigating preexisting type 1 or type 2 diabetes during pregnancy, the choice of medication can feel overwhelming. You might be worried about whether certain drugs could harm your baby or if they will effectively control your glucose levels to prevent complications like large-for-gestational-age infants or preeclampsia.
The good news is that we have clear guidelines from major health organizations like the Endocrine Society and the American College of Obstetricians and Gynecologists (ACOG). These guidelines help doctors choose treatments that keep both you and your baby safe. While insulin remains the gold standard because it does not cross the placenta, oral options like metformin play a specific, limited role. Understanding these options helps you make informed decisions alongside your healthcare team.
Why Glucose Control Matters More Than Ever
Your body undergoes massive hormonal changes during pregnancy, which naturally increase insulin resistance. For some women, the pancreas cannot produce enough extra insulin to compensate, leading to high blood sugar. Uncontrolled hyperglycemia poses risks such as congenital anomalies, stillbirth, and neonatal hypoglycemia (low blood sugar in the newborn).
To mitigate these risks, strict glucose targets are essential. According to the 2023 Endocrine Society guidelines, your goals should generally be:
- Fasting blood glucose: less than 95 mg/dL (5.3 mmol/L)
- One-hour postprandial (after eating): less than 140 mg/dL (7.8 mmol/L)
- Two-hour postprandial: less than 120 mg/dL (6.7 mmol/L)
Hitting these numbers consistently reduces the likelihood of needing an induction or C-section due to fetal size and lowers the risk of your baby needing intensive care after birth.
Insulin: The Gold Standard for Safety
Insulin is a hormone therapy that remains the primary pharmacological treatment for diabetes during pregnancy because it does not cross the placenta in significant amounts. This means the medication stays in your bloodstream to manage your glucose without directly exposing the fetus to the drug itself.
Not all insulins are created equal when it comes to pregnancy. The Joslin Diabetes Center’s 2022 guidelines highlight important distinctions between types:
| Insulin Type | Examples | Pregnancy Status |
|---|---|---|
| Rapid-Acting Analogs | Lispro, Aspart | Preferred: Better post-meal control, lower hypoglycemia risk compared to regular insulin. |
| Long-Acting Analogs | Detemir, Glargine | Acceptable: Studies show comparable safety to NPH insulin, though data is observational. |
| Older Insulins | NPH, Regular | Standard: Long history of use, but higher risk of hypoglycemia and weight gain. |
| Newer Analogs | Glulisine, Degludec | Not Recommended: Lack adequate safety data for use during pregnancy. |
You may also hear about Continuous Subcutaneous Insulin Infusion (CSII), commonly known as insulin pumps. Research indicates that pumps can lead to lower HbA1c levels and reduced total insulin requirements at delivery compared to multiple daily injections (MDI). However, studies show no significant difference in maternal or neonatal outcomes between the two methods, so the choice often comes down to personal preference and lifestyle compatibility.
Metformin: Effective But With Caveats
Metformin is an oral biguanide medication often used for type 2 diabetes and PCOS, which crosses the placenta and affects fetal metabolism. It has become a popular alternative to insulin for many women with gestational diabetes mellitus (GDM) because it is taken orally and has a lower risk of causing hypoglycemia.
A 2019 network meta-analysis published in NIH databases found that metformin was associated with lower risks of large-for-gestational-age (LGA) births, macrosomia, and NICU admissions compared to insulin. It also showed reduced rates of neonatal hypoglycemia and preeclampsia. Despite these benefits, there is a catch: approximately 50% of women on metformin eventually require supplemental insulin because the drug alone fails to maintain target glucose levels as pregnancy progresses and insulin resistance increases.
Furthermore, because metformin crosses the placenta, experts debate its long-term effects on the child. Some concerns exist regarding its impact on the mTOR pathway and potential epigenetic changes affecting the child’s metabolic health later in life. Consequently, the Endocrine Society (2023) recommends against routinely adding metformin to insulin for women with preexisting type 2 diabetes, citing that the benefit of reducing LGA infants does not outweigh the potential harm of increasing small-for-gestational-age (SGA) infant risks.
Medications to Avoid or Discontinue
If you were taking newer diabetes medications before conceiving, timing is critical. The landscape for these drugs has shifted significantly based on recent evidence.
GLP-1 Receptor Agonists: Drugs like semaglutide (Ozempic/Wegovy) and liraglutide (Victoza) are highly effective for weight loss and glucose control but are currently contraindicated during pregnancy. The Endocrine Society now recommends discontinuing these agents before conception rather than waiting until early pregnancy. This change reflects growing caution due to limited human safety data and animal studies suggesting potential developmental toxicity.
SGLT2 Inhibitors and DPP-4 Inhibitors: Medications such as empagliflozin (Jardiance) and sitagliptin (Januvia) lack sufficient safety data for use in pregnancy. The Joslin Diabetes Center explicitly states they should not be used. If you are on these, your doctor will likely transition you to insulin well before you try to conceive.
Preconception Planning: Setting the Stage
Effective diabetes management starts before you get pregnant. The Oregon Health & Science University (OHSU) Diabetes and Pregnancy Program emphasizes that preconception optimization drastically improves outcomes. Key steps include:
- Target HbA1c: Aim for an HbA1c below 6.5% before conception. Higher levels significantly increase the risk of congenital anomalies.
- Contraception Counseling: If your HbA1c is above 10%, doctors strongly recommend using long-acting reversible contraceptives (LARC) to delay pregnancy until glucose levels are optimized.
- Aspirin Prophylaxis: Starting low-dose aspirin (81-100 mg daily) at 12 weeks gestation is recommended by ACOG and Joslin to prevent preeclampsia, a serious complication linked to diabetes.
Transitioning off unsafe medications like GLP-1s or SGLT2 inhibitors during this phase ensures that your body is in the best possible state for a healthy pregnancy.
Monitoring and Delivery Considerations
Once pregnant, monitoring becomes intense. You will likely need to check your blood sugar four times a day-fasting and one hour after each meal. Continuous Glucose Monitors (CGMs) are increasingly used, especially for type 1 diabetes, as they provide real-time data and alerts for highs and lows. While direct evidence for CGM superiority over fingersticks in type 2 diabetes during pregnancy is still emerging, indirect evidence suggests improved glycemic metrics.
During labor, glucose management continues. ACOG guidelines suggest hourly glucose monitoring during active labor. Because stress hormones can raise blood sugar, you may receive intravenous insulin to keep levels stable. After delivery, most women with gestational diabetes can stop their medications immediately, as insulin resistance drops rapidly once the placenta is delivered. Women with preexisting diabetes will adjust their doses downward, often requiring significantly less insulin than during the third trimester.
Is insulin safe for the baby?
Yes, insulin is considered very safe. It is a large molecule that does not cross the placenta in significant amounts, meaning the baby is not directly exposed to the medication. It is the preferred treatment for both gestational and preexisting diabetes during pregnancy.
Can I take metformin throughout my entire pregnancy?
Many women do, but it depends on your case. Metformin crosses the placenta, so while it reduces the risk of large babies, about half of women still need insulin later in pregnancy. Discuss long-term fetal exposure risks with your endocrinologist.
What if I am on Ozempic or Wegovy?
You should stop these GLP-1 receptor agonists before trying to conceive. Current guidelines recommend discontinuation prior to pregnancy due to insufficient safety data and potential risks to fetal development.
Do I need to wear a continuous glucose monitor (CGM)?
While not mandatory for everyone, CGMs are highly beneficial, especially for type 1 diabetes. They help prevent dangerous highs and lows and provide detailed data for your doctor to adjust your insulin regimen accurately.
When do I stop taking diabetes medication after birth?
For gestational diabetes, most women stop all medications immediately after delivery. For preexisting diabetes, insulin doses usually drop significantly right after birth and must be carefully adjusted to avoid hypoglycemia.
Man, this article is a lifesaver for anyone freaking out about their glucose numbers right now. I was on metformin for my first pregnancy and thought it was the golden ticket because I hated needles. Spoiler alert: it wasn't. By week 28, my fasting numbers were creeping up no matter how strictly I cut carbs, so my endo added insulin anyway. It feels like a betrayal of your body when you have to start injecting, but honestly? The peace of mind knowing that insulin doesn't cross the placenta is worth every single prick. Don't let the fear of needles stop you from using the gold standard if you need it.